Zheng Zhang Selected Research

2-(2-benzofuranyl)-2-imidazoline

1/2020	Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood-Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion.
12/2018	2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain.
11/2018	Protective effects of 2-(2-benzonfuranyl)-2-imidazoline combined with tissue plasminogen activator after embolic stroke in rats.
6/2018	2-(2-Benzofuranyl)-2-Imidazoline Mediates Neuroprotection by Regulating the Neurovascular Unit Integrity in a Rat Model of Focal Cerebral Ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Zhang Research Topics

Disease

206	Neoplasms (Cancer) 04/2024 - 02/2002
73	COVID-19 04/2024 - 01/2020
68	Inflammation (Inflammations) 02/2024 - 08/2002
65	Infections 05/2024 - 07/2005
45	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2005
44	Fibrosis (Cirrhosis) 03/2024 - 02/2007
39	Hypoxia (Hypoxemia) 12/2023 - 08/2005
32	Carcinogenesis 01/2024 - 08/2005
31	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2009
25	Myocardial Infarction 01/2024 - 01/2012
22	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2005
21	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 02/2012
21	Wounds and Injuries (Trauma) 07/2023 - 08/2002
21	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 08/2008
19	Stroke (Strokes) 01/2024 - 02/2012
19	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 08/2018
18	Carcinoma (Carcinomatosis) 11/2023 - 12/2004
17	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 03/2006
17	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 12/2009
17	Chronic Hepatitis B 11/2023 - 05/2005
16	Diabetic Nephropathies (Diabetic Nephropathy) 05/2024 - 01/2012
16	Disease Progression 12/2023 - 06/2007
16	Ischemia 01/2023 - 07/2005
15	Reperfusion Injury 01/2023 - 02/2008
14	Hypertension (High Blood Pressure) 02/2024 - 11/2003
14	ST Elevation Myocardial Infarction 02/2024 - 07/2013
14	Lung Neoplasms (Lung Cancer) 12/2023 - 10/2004
14	Cicatrix (Scar) 09/2023 - 07/2012
14	Urinary Bladder Neoplasms (Bladder Cancer) 09/2019 - 04/2007
13	Ischemic Stroke 04/2024 - 01/2013
12	Atherosclerosis 12/2023 - 12/2012
12	Virus Diseases (Viral Diseases) 03/2022 - 12/2005
11	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024 - 05/2005
11	Periodontitis 01/2024 - 01/2020
11	Obesity 01/2024 - 11/2003
11	Non-alcoholic Fatty Liver Disease 10/2023 - 09/2011
11	Thrombosis (Thrombus) 01/2023 - 09/2012
11	Hepatitis B 06/2022 - 12/2007
10	Hypertrophic Cicatrix (Hypertrophic Scar) 12/2023 - 12/2014
10	Infarction (Infarctions) 06/2022 - 01/2012
10	Lymphatic Metastasis 05/2022 - 03/2013
9	Type 2 Diabetes Mellitus (MODY) 09/2023 - 01/2016
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 01/2015
9	Nasopharyngeal Carcinoma 01/2017 - 02/2002
8	Sepsis (Septicemia) 01/2024 - 01/2015
8	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2004
8	Hemorrhage 07/2023 - 04/2016
8	Adenocarcinoma 07/2023 - 12/2016
8	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 07/2013

Drug/Important Bio-Agent (IBA)

91	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
55	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2009
43	RNA (Ribonucleic Acid)IBA 02/2024 - 08/2006
39	CytokinesIBA 11/2023 - 04/2003
30	Long Noncoding RNAIBA 03/2024 - 11/2011
30	MicroRNAs (MicroRNA)IBA 01/2024 - 11/2009
28	Messenger RNA (mRNA)IBA 01/2024 - 10/2004
25	AntigensIBA 05/2024 - 06/2006
23	VaccinesIBA 12/2023 - 11/2008
20	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 11/2003
18	CollagenIBA 12/2023 - 07/2012
16	Antiviral Agents (Antivirals)IBA 04/2023 - 12/2007
15	Therapeutic UsesIBA 02/2024 - 05/2005
15	LipidsIBA 01/2024 - 11/2003
15	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 09/2005
14	Indicators and Reagents (Reagents)IBA 01/2024 - 02/2002
14	Neutralizing AntibodiesIBA 07/2023 - 03/2014
13	InterferonsIBA 11/2023 - 09/2005
13	Transcription Factors (Transcription Factor)IBA 12/2022 - 09/2005
13	EnzymesIBA 10/2021 - 04/2013
12	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2015
12	Small Interfering RNA (siRNA)IBA 01/2024 - 01/2007
11	AntibodiesIBA 05/2024 - 01/2015
11	Circular RNAIBA 04/2024 - 06/2019
11	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024 - 11/2016
11	InterleukinsIBA 01/2024 - 09/2005
11	Peptides (Polypeptides)IBA 01/2022 - 12/2007
11	Genetic Markers (Genetic Marker)IBA 01/2020 - 01/2009
10	ChemokinesIBA 12/2023 - 09/2005
10	Decitabine FDA Link 01/2020 - 10/2012
9	Phosphotransferases (Kinase)IBA 02/2024 - 09/2005
9	Sirtuin 1IBA 05/2023 - 04/2016
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 02/2009
9	PolymersIBA 01/2021 - 05/2008
8	omega-Chloroacetophenone (Mace)IBA 02/2024 - 01/2014
8	Interleukin-10 (Interleukin 10)IBA 01/2024 - 04/2003
8	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 05/2014
8	Neuroprotective AgentsIBA 02/2023 - 08/2016
8	Sirolimus (Rapamycin)FDA Link 01/2023 - 01/2015
8	Monoclonal AntibodiesIBA 01/2023 - 05/2009

Therapy/Procedure

132	Therapeutics 04/2024 - 12/2004
25	Drug Therapy (Chemotherapy) 04/2024 - 03/2005
14	Radiotherapy 09/2023 - 02/2002
12	Immunotherapy 04/2024 - 11/2008
12	Percutaneous Coronary Intervention 02/2024 - 07/2013
12	Stents 03/2023 - 01/2014
11	Aftercare (After-Treatment) 08/2023 - 09/2009
10	Length of Stay 12/2023 - 01/2014
9	Transplantation 10/2018 - 03/2007
8	Photochemotherapy (Photodynamic Therapy) 04/2024 - 11/2016
8	Liver Transplantation 12/2023 - 02/2007